NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
Andrew D. Zelenetz,Leo Gordon,Jeremy S. Abramson,Ranjana H. Advani,Babis Andreadis,Nancy L. Bartlett,L. Elizabeth Budde,Paolo F. Caimi,Julie E. Chang,Beth Christian,Sven DeVos,Bhagirathbhai Dholaria,Luis E. Fayad,Thomas M. Habermann,Muhammad Saad Hamid,Francisco Hernandez-Ilizaliturri,Boyu Hu,Mark S. Kaminski,Yasmin Karimi,Christopher R. Kelsey,Rebecca King,Susan Krivacic,Ann S. LaCasce,Megan Lim,Marcus Messmer,Mayur Narkhede,Rachel Rabinovitch,Praveen Ramakrishnan,Erin Reid,Kenneth B. Roberts,Hayder Saeed,Stephen D. Smith,Jakub Svoboda,Lode J. Swinnen,Joseph Tuscano,Julie M. Vose,Mary A. Dwyer,Hema Sundar JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK（2023）
Key words
Mantle Cell Lymphoma,T Cell Therapy,B-Cell Receptor Signaling
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper